Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 247 clinical trials
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (MAGNOLIA)

This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients with gastrointestinal (GI)/genitourinary (GU) cancer associated VTE (Magnolia)

cancer
deep venous thrombosis of lower extremity
deep vein thrombosis
dalteparin
pulmonary embolism
  • 0 views
  • 21 Jul, 2022
  • 1 location
A Multicenter, Randomized, Open-label, Blinded Endpoint Evaluation, Phase 3 Study Comparing the Effect of Abelacimab Relative to Apixaban on Venous Thromboembolism (VTE) Recurrence and Bleeding in Patients With Cancer Associated VTE (ASTER)

This is a Phase 3,multicenter, randomized, open-label, blinded endpoint evaluation study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE (ASTER)

cancer
deep vein thrombosis
pulmonary embolism
thrombosis
targeted therapy
  • 0 views
  • 16 Sep, 2022
  • 11 locations
sFlt1/PlGF and Selective Labor Induction to Prevent Preeclampsia at Term (PE37)

Preeclampsia (PE) affects ~5% of pregnancies. Although improved obstetrical care has significantly diminished associated maternal mortality, PE remains a leading cause of maternal

cesarean section
prenatal
Accepts healthy volunteers
  • 0 views
  • 16 May, 2022
  • 12 locations
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism (HI-PRO)

VTE, defined as the composite of deep vein thrombosis and/or pulmonary embolism at 12 months. Secondary Efficacy Outcome: The composite of death due to cardiovascular cause, nonfatal

asthma
heart failure
pulmonary embolism
COPD
stroke
  • 0 views
  • 29 Jul, 2022
  • 1 location
Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease (EuroPE)

trials. The main objective of this study is to determine the effects of the use of the ratio as a diagnostic tool in the definition and classification of PE, as compared with its usual definition, in

edema
prenatal
hypertension
toxemia of pregnancy
proteinuria
  • 0 views
  • 25 May, 2022
  • 1 location
Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events

The study will evaluate the effectiveness of a novel, real-time risk prediction model for identifying pediatric patients at risk for developing in-hospital blood clots (or venous thromboembolism [VTE]) based on data easily extracted from the electronic medical record. The study will assess whether using the risk percentages for developing VTE …

venous thromboembolism
blood clot
clot
thromboembolism
  • 0 views
  • 06 Mar, 2022
  • 1 location
Labor Induction in Preeclampsia High-risk Women (FORECAST-IOL)

Preeclampsia (PE) is one of the leading causes of maternal and perinatal morbidity and mortality. This pregnancy-specific disorder poses to both pregnant women and their offspring an increased

perinatal morbidity
  • 0 views
  • 13 Jun, 2022
  • 1 location
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) (Jason)

/ Pulmonary Embolism (DVT/PE) recurrence.

hypertension
secondary prevention
deep vein thrombosis
pulmonary embolism
thrombosis
  • 0 views
  • 24 Jul, 2022
  • 1 location
Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis

superficial venous thrombosis (SVT), deep venous thrombosis (DVT), pulmonary embolism (PE)) in patients who have completed the cycle of therapy of the acute phase after superficial vein thrombosis.

  • 9 views
  • 02 Mar, 2022
  • 1 location
Pre- vs Postoperative Thromboprophylaxis for Liver Resection

Thromboprophylaxis for liver surgery can be commenced either preoperatively or postoperatively. Despite a clear trade-off between thrombosis and bleeding in liver surgery patients, there is no international consensus when thrombosis prophylaxis should be commenced in patients undergoing liver surgery. As far as we know, there are no prospective randomized trials …

tinzaparin
cancer
dalteparin
thrombosis
thromboembolism prophylaxis
  • 0 views
  • 15 Jun, 2021
  • 6 locations